(Q34568559)

3 August 2017

1 reference

title

Modifiers of risk of hereditary breast cancer (English)

1 reference

3 August 2017

1 reference

1

Narod SA

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 September 2006

1 reference

3 August 2017

1 reference

3 August 2017

volume

25

1 reference

3 August 2017

issue

43

1 reference

3 August 2017

page(s)

5832-5836

1 reference

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209870

Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209870

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209870

Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209870

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209870

Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209870

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209870

Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209870

Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209870

Predictors of the plasma ratio of 2-hydroxyestrone to 16alpha-hydroxyestrone among pre-menopausal, nulliparous women from four ethnic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209870

Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209870

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209870

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209870

Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209870

Towards a dietary prevention of hereditary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209870

Increased rates of chromosome breakage in BRCA1 carriers are normalized by oral selenium supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209870

Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209870

Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209870

Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209870

Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209870

Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209870

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209870

Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209870

Mammary gland architecture as a determining factor in the susceptibility of the human breast to cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209870

Influence of age and parity on the development of the human breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209870

Cancer risks in BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209870

Variation in cancer risks, by mutation position, in BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209870

Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209870

A comparison of bilateral breast cancers in BRCA carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209870

Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209870

Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209870

7 January 2021

A polymorphic stop codon in BRCA2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209870

7 January 2021

Increasing incidence of breast cancer in family with BRCA1 mutation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209870

7 January 2021

Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209870

7 January 2021

Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209870

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209870

1 reference

Dimensions Publication ID

3 August 2017

1014163684

0 references

1 reference